References
- Acarturk, E., Attila, G., Bozkurt, A., Akplnar, O., Matyar, S. and Seydaoglu, G. (2005) Insertion/deletion polymorphism of the angiotensin converting enzyme in coronary artery disease in Southern Turkey. J. Biochem. Mol. Biol. 38, 486-490. https://doi.org/10.5483/BMBRep.2005.38.4.486
- Akins, R. L. and Rybak, M. J. (2001) Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycinresistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus isolates in and in vitro pharmacodynamic model with simulated endocardial vegetation. Antimicrob. Agents Chemother. 45, 454-459. https://doi.org/10.1128/AAC.45.2.454-459.2001
- Betriu, C., Gomez, M., Rodriguez-Avial, I., Culebras, E. and Picazo, J. J. (2005) In vitro activity of tigecycline against ampicillinresistant Haemophilus influenzae isolates. J. Antimicrob. Chemother. 55, 809-810. https://doi.org/10.1093/jac/dki096
- Bouchillon, S. K., Hoban, D. J., Johnson, B. M., Stevens, T. M., Dowzicky, M. J., Wu, D. H. and Bradford, P. A. (2005) In vitro evaluation of tigecycline and comparative agents in 3,049 clinical isolates: 2001 to 2002. Diagn. Microbiol. Infect. Dis. 51, 291-295. https://doi.org/10.1016/j.diagmicrobio.2004.11.006
- Centers for Disease Control and Prevention (1993) Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. Morbid. Mortal. Weekly Rep. 42, 597-599.
- Choi, S. S., Kim, B. S. and Ha, N. J. (2002) Isolation, identification and characterization of vancomycin-resistant enterococci from raw milk. J. Microbiol. 40, 170-172.
- Choi, J. H., Zhang, P. C., Park, K. W., Cho, Y. S. and Oh, B. H. (2005) The association between the T102C polymorphism of the HTR2A serotonin receptor gene and HDL cholesterol level in Koreans. J. Biochem. Mol. Biol. 38, 238-242. https://doi.org/10.5483/BMBRep.2005.38.2.238
- Diekema, D. J. and Jones, R. N. (2001) Oxazolidinone antibiotics. Lancet 358, 1975-1982. https://doi.org/10.1016/S0140-6736(01)06964-1
- Emori, T. G. and Gaynes, R. P. (1993) An overview of nosocomial infections, including the role of microbiology laboratory. Clin. Microb. Drug Resist. 6, 313-318.
- Fritsche, T. R., Sader, H. S., Stilwell, M. G., Dowzicky, M. J and Jones, R. N. (2005a) Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Diagn. Microbiol. Infect. Dis. 52, 187-193. https://doi.org/10.1016/j.diagmicrobio.2005.05.004
- Fritsche, T. R., Sader, H. S., Stilwell, M. G., Dowzicky, M. J. and Jones, R. N. (2005b) Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Diagn. Microbiol. Infect. Dis. 52, 195-201. https://doi.org/10.1016/j.diagmicrobio.2005.05.003
- Fuchs, P. C., Barry, A. L. and Brown, S. D. (2000) Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagn. Microbiol. Infect. Dis. 38, 51-58. https://doi.org/10.1016/S0732-8893(00)00164-4
- Hsueh, P. R., Chen, W. H., Teng, L. J and Luh, K. T. (2005) Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int. J. Antimicrob. Agents 26, 43-49. https://doi.org/10.1016/j.ijantimicag.2005.04.007
- Jones, R. N. (2003) Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a fiveyear summary from the Sentry Antimicrobial Surveillance Program (1997-2001). Semin. Respir. Crit. Care Med. 24, 121-133. https://doi.org/10.1055/s-2003-37923
- Kim, J. M. and Song, Y. G. (1998) Vancomycin-resistant enterococcal infections in Korea. Yonsei Med. J. 39, 562-568. https://doi.org/10.3349/ymj.1998.39.6.562
- Kim, S. M., Shim, E. S. and Seong, C. N. (2001) Prevalence and antibiotic susceptibility of vancomycin-resistant enterococci in chicken intestines and fecal samples from healthy young children and intensive care unit patients. J. Microbiol. 39, 116-120.
- Klare, I., Heier, H., Claus, H., Reissbrodt, R. and Witte, W. (1995) VanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. Fems Microbiol. Lett. 125, 165-172. https://doi.org/10.1111/j.1574-6968.1995.tb07353.x
- LaPlante, K. L. and Rybak, M. J. (2004) Clinical glycopeptideintermediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagn. Microbiol. Infect. Dis. 50, 125-130. https://doi.org/10.1016/j.diagmicrobio.2004.06.014
- Meka, V. G. and Gold, H. S. (2004) Antimicrobial resistance to linezolid. Clin. Infect. Dis. 39, 1010-1015. https://doi.org/10.1086/423841
- Moellering, R. C. (1992) Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis. 14, 1173-1178. https://doi.org/10.1093/clinids/14.6.1173
- Nathwani, D. (2005) Tigecycline: clinical evidence and formulary positioning. Int. J. Antimicrob. Agents 25, 185-192. https://doi.org/10.1016/j.ijantimicag.2004.11.006
- National Committee for Clinical Laboratory Standards (NCCLS) (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne PA: NCCLS.
- National Committee for Clinical Laboratory Standards (NCCLS) (2005) Performance standards for antimicrobial susceptibility testing, 15th information supplement M100-S15. Wayne PA: NCCLS.
- Package insert (2003) Cubicin (daptomycin for infection). Lexington MA. (Cubist Phamaceuticals, Inc.) Available at http://www.cubist.com/shared/cubicin_label.pdf. Accessed on September 22, 2003.
- Patel, R. (2003) Clinical impact of vancomycin-resistant enterococci. J. Antimicrob. Chemother. 51 (Suppl.), 13-21.
- Raad, I., Hachem, R. and Hanna, H. (2001) Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline. Antimicrob. Agents Chemother. 45, 3202-3204. https://doi.org/10.1128/AAC.45.11.3202-3204.2001
- Raad, I., Hachem, R., Hanna, H., Afif, C., Escalante, C., Kantarjian, H. and Rolston, K. (2004) Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections J. Antimicrob. Chemother. 53, 646-649. https://doi.org/10.1093/jac/dkh144
- Ross, J. E., Anderegg, T. R., Sader, H. S., Fritsche, T. R. and Jones, R. N. (2004) Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program. Diagn. Microbiol. Infect. Dis. 52, 53-58.
- Sader, S. H., Fritsche, T. R. and Jones, R. N. (2005) Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003). Diagn. Microbiol. Infect. Dis. 53, 329-332. https://doi.org/10.1016/j.diagmicrobio.2005.07.001
- Sader, H. S., Jones, R. N., Dowzicky, M. J. and Fritsche, T. R. (2005) Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn. Microbiol. Infect. Dis. 52, 203-208. https://doi.org/10.1016/j.diagmicrobio.2005.05.002
- Sader, H. S., Streit, J. M., Fritsche, T. R. and Jones, R. N. (2004) Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide. Diagn. Microbiol. Infect. Dis. 50, 201-204. https://doi.org/10.1016/j.diagmicrobio.2004.07.002
- Sakouloas, G., Eliopoulos, G. M., Alder, J. and Thauvin-Eliopoulos, C. (2003) Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47, 1714-1718. https://doi.org/10.1128/AAC.47.5.1714-1718.2003
- Smith, P. F., Booker, B. M., Ogundele, A. B. and Kelchin, P. (2005) Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center. Diagn. Microbiol. Infect. Dis. 52, 255-259. https://doi.org/10.1016/j.diagmicrobio.2005.02.015
- Steenbergen, J. N., Alder, J., Thorne, G. M. and Talley, F. P. (2005) Dpatomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J. Antimicrob. Chemother. 55, 283-288. https://doi.org/10.1093/jac/dkh546
- Streit, J. M., Jones, R. N. and Sader, H. S. (2004) Daptomycin activity and spectrum: A worldwide sample of 6,737 Grampositive organisms. J. Antimicrob. Chemother. 53, 669-674. https://doi.org/10.1093/jac/dkh143
- Wenzel, R. P. (2004) The antibiotic pipeline-challenges, costs and values. N. Engl. J. Med. 351, 523-526. https://doi.org/10.1056/NEJMp048093
- Wesson, K. M., Lerner, D. S., Silverberg, N. B. and Weinberg, J. M. (2004) Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology. Dis. Mon. 50, 395-406. https://doi.org/10.1016/j.disamonth.2004.05.010
- Witte, W. (1997) Impact of antibiotic use in animal feeding on resistance of bacterial pathogens in humans. Ciba. Found. Symp. 207, 61-71.
- World Health Organization (WHO) WHO Global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001.2.
- Yang, J. W., Lee, D. K., Kim, Y. A., Kang, B. Y., Kim, K. J. and Ha, N. J. (2007) Occurrence of the van genes in Enterococcus faecalis and Enterococcus faecium from clinical isolates in Korea. Arch. Pharm. Res. 30, 329-336. https://doi.org/10.1007/BF02977614
Cited by
- Characterization ofEnterocccus faecalisIsolates from the Pork Meat Production Chain and Comparison with Human Clinical Isolates vol.33, pp.2, 2013, https://doi.org/10.1111/jfs.12039
- Prevalence of phenotypic resistance of Staphylococcus aureus isolates to macrolide, lincosamide, streptogramin B, ketolid and linezolid antibiotics in Turkey vol.14, pp.1, 2010, https://doi.org/10.1016/S1413-8670(10)70003-9
- An update on emerging therapies for urinary tract infections vol.22, pp.1, 2017, https://doi.org/10.1080/14728214.2017.1293650
- Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies vol.68, pp.suppl 2, 2013, https://doi.org/10.1093/jac/dkt140
- Total Occlusive Ionic Silver-Containing Dressing vs Mupirocin Ointment Application vs Conventional Dressing in Elective Colorectal Surgery: Effect on Incisional Surgical Site Infection vol.221, pp.2, 2015, https://doi.org/10.1016/j.jamcollsurg.2015.04.019
- Antibiotic resistance and assessment of food-borne pathogenic bacteria in frozen foods vol.32, pp.12, 2009, https://doi.org/10.1007/s12272-009-2213-y
- Resistance to and synthesis of the antibiotic mupirocin vol.8, pp.4, 2010, https://doi.org/10.1038/nrmicro2278
- Flow Cytometry Approach Study of Enterococcus faecalis Vancomycin Resistance by Detection of Vancomycin@FL Binding to the Bacterial Cells vol.61, pp.5, 2010, https://doi.org/10.1007/s00284-010-9628-z
- Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp. vol.63, pp.6, 2010, https://doi.org/10.1038/ja.2010.29
- Peritoneal dialysis-associated peritonitis caused by vancomycin-resistant Enterococcus: Comprehensive review on treatment options vol.17, pp.2, 2015, https://doi.org/10.1016/j.hkjn.2015.03.003
- A novel nano drug delivery system based on tigecycline-loaded calciumphosphate coated with poly-dl-lactide-co-glycolide vol.21, pp.1, 2010, https://doi.org/10.1007/s10856-009-3854-6
- Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis vol.67, pp.9, 2012, https://doi.org/10.1093/jac/dks181
- Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital vol.46, pp.4, 2014, https://doi.org/10.3947/ic.2014.46.4.253
- Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians vol.52, pp.2, 2011, https://doi.org/10.1093/cid/ciq113